{"nct_id":"NCT05092581","title":"COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19","status":"TERMINATED","status_verified_date":"2022-07","start_date":"2021-12-16","start_date_type":"ACTUAL","primary_completion_date":"2022-06-09","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["REGN"]}